drugset / Trial / NCT02243241

The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

NCT02243241

Phase 1 Completed 208 enrolled Purdue Pharma LP
RandomizedParallel-groupTriple-blind

Summary

Evaluate the effect of multiple doses (once daily for 3 days each of HYD 80, 120, and 160 mg tablets) on the QT/QTc interval.

Timeline

Start
2012-11
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocodone Unknown 160 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.